Naurex
Company

Last deal

$38M

Amount

Series B

Stage

25.05.2022

Date

3

all rounds

$200.11M

Total amount

date founded

Financing round

General

About Company
Naurex is a clinical-stage company developing novel therapeutics for depression and other CNS disorders.

Industry

Sector :

Subsector :

founded date

01.01.2008

Number of employees

Company Type

For Profit

Last funding type

Series B

IPO status

Private

Description

Naurex is a biopharmaceutical company that develops therapies to address unmet needs in psychiatry and neurology by modulating the NMDA receptor in a safe way. Their lead product candidate, rapastinel (GLYX-13), is in late-stage clinical development as an adjunctive therapy for patients with major depressive disorder. Naurex's second-generation compound, NRX-1074, is an orally active agent in Phase 2 clinical development as a monotherapy for the treatment of major depressive disorder. Naurex was acquired by Allergan plc in August 2015.
Contacts

Contact Email

Phone number

Social url

Similar Companies
1000
Corcept Therapeutics

Corcept Therapeutics

Corcept Therapeutics develops drugs that regulate the effects of cortisol.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Health Care, Pharmaceuticals

Location

Menlo Park, CA, USA

total rounds

8

total raised

$119.09M
Synendos Therapeutics

Synendos Therapeutics

Synendos Therapeutics develops small molecules for anxiety and stress-related disorders.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Health Care, Therapeutics

Location

4123 Allschwil, Switzerland

total rounds

5

total raised

$38.9M
Axsome Therapeutics

Axsome Therapeutics

Axsome Therapeutics develops and sells therapies for pain and neurological disorders.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Location

New York, NY, USA

total rounds

6

total raised

$431.99M
Syndesi Therapeutics

Syndesi Therapeutics

Syndesi Therapeutics develops drug molecules to treat cognitive impairment by modulating the synaptic vesicle protein SV2A.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Health Care, Therapeutics

Location

Louvain-la-Neuve, 1348 Ottignies-Louvain-la-Neuve, Belgium

total rounds

3

total raised

$26M
M&A Details
1

Transaction name

Acquired by

Allergan

announced date

27.07.2015

price

$560M

Financials

Funding Rounds
6
3

Number of Funding Rounds

$200.11M

Money Raised

Their latest funding was raised on 25.05.2022. Their latest round Series B

Date 
Funding Round 
Investors 
Money Raised 
Lead 
Savitr Capital

Savitr Capital

Savitr Capital is an investment management firm that specializes in renewable and clean energy companies.

Sector

Investment Banking and Brokerage Services

Subsector

Asset Managers and Custodians

Location

San Francisco, CA, USA

count Of Investments

6

count Of Exists

1
Portal Capital

Portal Capital

Portal Capital is a Cleveland-based private equity investment firm.

Sector

Investment Banking and Brokerage Services

Subsector

Asset Managers and Custodians

Keywords

Financial Services, Venture Capital, Finance

Location

Beachwood, OH 44122, USA

count Of Investments

6

count Of Exists

4

PathoCapital

PathoCapital is a healthcare-focused venture fund.

Sector

Closed End Investments

Subsector

Closed End Investments

Keywords

Health Care, Financial Services, Venture Capital

Location

Northbrook, IL 60062, USA

count Of Investments

6

count Of Exists

1
Baxter Ventures

Baxter Ventures

Baxter Ventures invests in innovative healthcare companies to improve patient care and maximize value for investors and entrepreneurs.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Health Care, Venture Capital

Location

Deerfield, IL, USA

count Of Investments

15

count Of Exists

3
Cowen Group

Cowen Group

Cowen Group is a financial services firm that offers equity and debt financings, investment banking, and other financial-related services.

Sector

Investment Banking and Brokerage Services

Subsector

Diversified Financial Services

Location

New York, NY, USA

total rounds

1

total raised

$53M

count Of Investments

37

count Of Exists

15
EcoR1 Capital

EcoR1 Capital

EcoR1 Capital is a biotech-focused investment advisory firm based in San Francisco.

Sector

Closed End Investments

Subsector

Closed End Investments

Location

San Francisco, CA, USA

count Of Investments

94

count Of Exists

7
Adams Street Partners

Adams Street Partners

Adams Street Partners is a global private markets investment manager that offers comprehensive solutions for its investors.

Sector

Closed End Investments

Subsector

Closed End Investments

Keywords

Financial Services, Finance

Location

Chicago, IL, USA

count Of Investments

209

count Of Exists

66
Sabby Capital

Sabby Capital

Sabby Capital is a New Jersey-based investment firm focused on healthcare.

Sector

Closed End Investments

Subsector

Closed End Investments

Keywords

Financial Services, Venture Capital

Location

Upper Saddle River, NJ 07458, USA

count Of Investments

13

count Of Exists

2

Druid BioVentures

Druid BioVentures invests in virtual drug companies developing novel drugs.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Location

Philadelphia, PA, USA

count Of Investments

3

count Of Exists

1
Co-Investors
Investors
15
10

Number of lead investors

15

Number of investors

Investor 
Lead 
Round 
Partners 
No
Series C
No
Series C
Baxter International

Baxter International

Baxter International Inc. develops and manufactures medical products for various chronic and acute medical conditions.

Sector

Medical Equipment and Services

Subsector

Medical Equipment

Keywords

Biotechnology, Health Care, Manufacturing

Location

Deerfield, IL, USA

total rounds

2

total raised

$1.68B

count Of Investments

13

count Of Exists

1
Lundbeck

Lundbeck

Lundbeck is a global pharmaceutical company specializing in brain diseases.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Location

Valby, Copenhagen, Denmark

total rounds

1

count Of Investments

3

count Of Exists

1
Shire

Shire

Shire is a global biotechnology company that focuses on serving people with rare diseases.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Pharmaceuticals, Financial Services, Biotechnology

Location

Dublin, Ireland

total rounds

1

count Of Investments

12

count Of Exists

3

People

Founders
1
Joseph Moskal
Joseph Moskal

Joseph Moskal

Joseph Moskal is chief scientific officer of Aptinyx. He founded Naurex and served as its chief scientific officer until the company was acquired by Allergan. He is also distinguished professor of biomedical engineering at Northwestern University and director of the university’s Falk Center for Molecular Therapeutics. Joseph Moskal previously served as assistant professor and director of the neurosurgery laboratories at the Albert Einstein College of Medicine. Earlier, he was a staff fellow at the National Institutes of Health. Joseph Moskal is well known for his research on the NMDA receptor. He received a B.S. and a Ph.D. from the University of Notre Dame.

current job

Molecular Therapeutics
Molecular Therapeutics

organization founded

2

Joseph Moskal

Employee Profiles
11
Norbert Riedel

Norbert Riedel

CEO and Board of Director

M. Amin Khan

Head of Chemistry

J. David Leander

J. David Leander

Chief Scientific Advisor

Joseph Moskal

Joseph Moskal

Founder & Chief Scientific Officer

Wilbur Gantz

Wilbur Gantz

Executive Chairman and Board of Director

Activity

Recent News
0